Pre-order Enquiry
Request Free Sample
Global T-UDCA Market Research Report 2022
SKU ID : QYR-20172025 | Publishing Date : 07-Feb-2022
Request Sample
Request Customization
Check Discounts
Tauroursodeoxycholic acid (TUDCA) is an ambiphilic bile acid. It is the taurine conjugate form of ursodeoxycholic acid (UDCA). Humans are found to have trace amounts of TUDCA.
Tauroursodeoxycholic acid (TUDCA) is a compound originally approved to treat liver diseases — but recent research suggests it may have a broader application.
TUDCA is closely related to ursodeoxycholic acid (UDCA), with some structural differences. TUDCA is one of the compounds found in bile acid. Bile acid is made by the liver and stored in the gallbladder and helps with digestion.
Recently, TUDCA is being used and tested in a wide variety of therapeutic areas to explore its effectiveness. Amongst others, TUDCA has been studied for the way in which it may relieve the symptoms of inflammatory diseases.
Due to the COVID-19 pandemic, the global T-UDCA market size is estimated to be worth US$ 69 million in 2021 and is forecast to a readjusted size of US$ 135.3 million by 2028 with a CAGR of 10.0% during the review period. Fully considering the economic change by this health crisis, the Europe T-UDCA market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe T-UDCA landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Global key T-UDCA players include Bruschettini, Nutricost and BodyBio etc. The top 3 companies hold a share about 43%. North America is the largest market with a share about 37%, followed by Asia-Pacific and Europe.
In terms of product, health supplement is the largest segment with a share about 80%. And in terms of applications, the largest application is retail pharmacy with a share about 66%.
This report focuses on T-UDCA volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall T-UDCA market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America and Europe., etc.
Global T-UDCA Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Drugs
Health Supplements
Segment by Application
Retail Pharmacy
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bruschettini
Nutricost
BodyBio
Double Wood Supplements
Vitaceutico
Best Naturals
Deal Supplement
Cellcore Biosciences
Max Life Naturals
HUMANX
Tauroursodeoxycholic acid (TUDCA) is a compound originally approved to treat liver diseases — but recent research suggests it may have a broader application.
TUDCA is closely related to ursodeoxycholic acid (UDCA), with some structural differences. TUDCA is one of the compounds found in bile acid. Bile acid is made by the liver and stored in the gallbladder and helps with digestion.
Recently, TUDCA is being used and tested in a wide variety of therapeutic areas to explore its effectiveness. Amongst others, TUDCA has been studied for the way in which it may relieve the symptoms of inflammatory diseases.
Due to the COVID-19 pandemic, the global T-UDCA market size is estimated to be worth US$ 69 million in 2021 and is forecast to a readjusted size of US$ 135.3 million by 2028 with a CAGR of 10.0% during the review period. Fully considering the economic change by this health crisis, the Europe T-UDCA market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe T-UDCA landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Global key T-UDCA players include Bruschettini, Nutricost and BodyBio etc. The top 3 companies hold a share about 43%. North America is the largest market with a share about 37%, followed by Asia-Pacific and Europe.
In terms of product, health supplement is the largest segment with a share about 80%. And in terms of applications, the largest application is retail pharmacy with a share about 66%.
This report focuses on T-UDCA volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall T-UDCA market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America and Europe., etc.
Global T-UDCA Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Drugs
Health Supplements
Segment by Application
Retail Pharmacy
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bruschettini
Nutricost
BodyBio
Double Wood Supplements
Vitaceutico
Best Naturals
Deal Supplement
Cellcore Biosciences
Max Life Naturals
HUMANX
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
